Patrick Trojer
2020
In 2020, Patrick Trojer earned a total compensation of $1.9M as Chief Scientific Officer at CONSTELLATION PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $154,800 |
|---|---|
| Option Awards | $1,392,023 |
| Salary | $387,000 |
| Other | $14,725 |
| Total | $1,948,548 |
Trojer received $1.4M in option awards, accounting for 71% of the total pay in 2020.
Trojer also received $154.8K in non-equity incentive plan, $387K in salary and $14.7K in other compensation.
Rankings
In 2020, Patrick Trojer's compensation ranked 5,639th out of 13,090 executives tracked by ExecPay. In other words, Trojer earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,639 out of 13,090 | 57th |
Division Manufacturing | 2,328 out of 5,621 | 59th |
Major group Chemicals And Allied Products | 929 out of 2,254 | 59th |
Industry group Drugs | 803 out of 1,954 | 59th |
Industry Pharmaceutical Preparations | 597 out of 1,459 | 59th |
Source: SEC filing on April 23, 2021.
Trojer's colleagues
We found four more compensation records of executives who worked with Patrick Trojer at CONSTELLATION PHARMACEUTICALS in 2020.